Arthur F. Ryan - 01 Jul 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Jul 2021
Net transactions value
-$56,450
Form type
4
Filing time
02 Jul 2021, 16:02:22 UTC
Previous filing
16 Jun 2021
Next filing
04 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,111 -2 -0.01% $555.47 23,589 01 Jul 2021 Direct F1
transaction REGN Common Stock Sale $2,227 -4 -0.02% $556.71 23,585 01 Jul 2021 Direct F1, F2
transaction REGN Common Stock Sale $558 -1 -0% $557.75 23,584 01 Jul 2021 Direct F1
transaction REGN Common Stock Sale $1,120 -2 -0.01% $559.78 23,582 01 Jul 2021 Direct F1
transaction REGN Common Stock Sale $1,121 -2 -0.01% $560.62 23,580 01 Jul 2021 Direct F1, F3
transaction REGN Common Stock Sale $3,371 -6 -0.03% $561.80 23,574 01 Jul 2021 Direct F1, F4
transaction REGN Common Stock Sale $5,625 -10 -0.04% $562.48 23,564 01 Jul 2021 Direct F1, F5
transaction REGN Common Stock Sale $9,014 -16 -0.07% $563.40 23,548 01 Jul 2021 Direct F1, F6
transaction REGN Common Stock Sale $3,388 -6 -0.03% $564.71 23,542 01 Jul 2021 Direct F1, F7
transaction REGN Common Stock Sale $7,351 -13 -0.06% $565.44 23,529 01 Jul 2021 Direct F1, F8
transaction REGN Common Stock Sale $6,797 -12 -0.05% $566.42 23,517 01 Jul 2021 Direct F1, F9
transaction REGN Common Stock Sale $7,378 -13 -0.06% $567.56 23,504 01 Jul 2021 Direct F1, F10
transaction REGN Common Stock Sale $7,390 -13 -0.06% $568.43 23,491 01 Jul 2021 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 4 shares of Company stock on July 1, 2021 at prices ranging from $556.60 to $556.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 2 shares of Company stock on July 1, 2021 at prices ranging from $560.43 to $560.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $561.57 to $561.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 10 shares of Company stock on July 1, 2021 at prices ranging from $562.00 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 16 shares of Company stock on July 1, 2021 at prices ranging from $563.03 to $563.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $564.26 to $564.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $565.00 to $565.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 12 shares of Company stock on July 1, 2021 at prices ranging from $566.09 to $566.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $567.15 to $567.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $568.10 to $568.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price.